IBRX vs. QQQ
IBRX (ImmunityBio, Inc.) is a stock, while QQQ (Invesco QQQ ETF) is Nasdaq-100 fund tracking the NASDAQ-100 Index. Over the past 10 years, IBRX returned 1.77%/yr vs 22.48%/yr for QQQ. At a 0.35 correlation, their price movements are largely independent.
Performance
IBRX vs. QQQ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IBRX achieves a 264.65% return, which is significantly higher than QQQ's 20.41% return. Over the past 10 years, IBRX has underperformed QQQ with an annualized return of 1.77%, while QQQ has yielded a comparatively higher 22.48% annualized return.
IBRX
- 1D
- -1.90%
- 1M
- 0.00%
- YTD
- 264.65%
- 6M
- 218.06%
- 1Y
- 151.57%
- 3Y*
- 38.97%
- 5Y*
- -12.44%
- 10Y*
- 1.77%
QQQ
- 1D
- -0.25%
- 1M
- 2.96%
- YTD
- 20.41%
- 6M
- 19.46%
- 1Y
- 40.91%
- 3Y*
- 27.47%
- 5Y*
- 16.94%
- 10Y*
- 22.48%
IBRX vs. QQQ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IBRX ImmunityBio, Inc. | 264.65% | -22.66% | -49.00% | -0.99% | -16.61% | -54.39% | 251.72% | 226.72% | -74.16% | -21.50% |
QQQ Invesco QQQ ETF | 20.41% | 20.77% | 25.58% | 54.86% | -32.58% | 27.42% | 48.62% | 38.96% | -0.13% | 32.66% |
Correlation
The correlation between IBRX and QQQ is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.30 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.30 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.39 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.35 |
Correlation (All Time) Calculated using the full available price history since Jul 28, 2015 | 0.35 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IBRX vs. QQQ — Risk / Return Rank
IBRX
QQQ
IBRX vs. QQQ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ImmunityBio, Inc. (IBRX) and Invesco QQQ ETF (QQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IBRX | QQQ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.87 | ||
| Sortino ratioReturn per unit of downside risk | -0.40 | ||
| Omega ratioGain probability vs. loss probability | 1.31 | 1.41 | -0.09 |
| Calmar ratioReturn relative to maximum drawdown | 3.60 | 3.44 | +0.17 |
| Martin ratioReturn relative to average drawdown | 6.15 | 12.79 | -6.63 |
Loading charts...
Drawdowns
IBRX vs. QQQ - Drawdown Comparison
The maximum IBRX drawdown since its inception was -97.30%, which is greater than QQQ's maximum drawdown of -82.97%. Use the drawdown chart below to compare losses from any high point for IBRX and QQQ.
Loading charts...
Drawdown Indicators
| IBRX | QQQ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.30% | -82.97% | -14.33% |
Max Drawdown (1Y)Largest decline over 1 year | -42.34% | -11.96% | -30.38% |
Max Drawdown (3Y)Largest decline over 3 years | -79.34% | -22.77% | -56.57% |
Max Drawdown (5Y)Largest decline over 5 years | -91.75% | -35.12% | -56.63% |
Max Drawdown (10Y)Largest decline over 10 years | -97.03% | -35.12% | -61.91% |
Current DrawdownCurrent decline from peak | -82.91% | -0.99% | -81.92% |
Average DrawdownAverage peak-to-trough decline | -84.38% | -32.73% | -51.65% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.76% | 3.21% | +21.55% |
Volatility
IBRX vs. QQQ - Volatility Comparison
ImmunityBio, Inc. (IBRX) has a higher volatility of 18.35% compared to Invesco QQQ ETF (QQQ) at 8.47%. This indicates that IBRX's price experiences larger fluctuations and is considered to be riskier than QQQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IBRX | QQQ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.35% | 8.47% | +9.88% |
Volatility (6M)Calculated over the trailing 6-month period | 88.53% | 14.20% | +74.33% |
Volatility (1Y)Calculated over the trailing 1-year period | 104.49% | 17.67% | +86.82% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 113.44% | 22.64% | +90.80% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 111.42% | 22.43% | +88.99% |
Dividends
IBRX vs. QQQ - Dividend Comparison
IBRX has not paid dividends to shareholders, while QQQ's dividend yield for the trailing twelve months is around 0.49%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IBRX ImmunityBio, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
QQQ Invesco QQQ ETF | 0.49% | 0.45% | 0.56% | 0.62% | 0.80% | 0.43% | 0.55% | 0.74% | 0.91% | 0.84% | 1.06% | 0.99% |
Frequently Asked Questions
IBRX and QQQ have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IBRX has higher volatility (18.35%) compared to QQQ (8.47%). In terms of maximum drawdown, IBRX dropped -97.30% vs QQQ's -82.97%.
QQQ currently has the higher Sharpe Ratio (2.33 vs 1.46), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IBRX and QQQ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer